Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 2006
ClinicalTrials.gov · Datasets · License: Public Domain · 2006
Open Source ↗
anemiacancer
anemia, cancer, epoetin alfa, non-chemotherapy-induced, non-radiation therapy-induced, non-myeloid, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 878101
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.